Cannsun

The standard for medical development

Pioneering Medical Advances

We are a science led global healthcare company looking towards the future. Cannsun has always been on the cutting edge of pharmaceuticals and healthcare, marked by a tradition of producing the latest in medical innovation. Today, Cannsun continues to grow and develop pharmaceutical solutions while merging traditional medicines to include cannabinoid alternatives.

Cannsun is Europe’s first medical manufacturer
with a vertically integrated cannabinoid division.

A Vision for the Future

The recent developments in cannabinoids have illustrated that their potential is endless and untapped. Cannsunn is dedicated to the production of high-quality healthcare, medical and wellness products that it has always been known for, in addition to providing the latest in medical cannabinoid development. Cannabis development is one of the fastest growing healthcare markets globally, and Cannsun is perfectly positioned to produce the latest products in line with these developments.

Cannsun Medhel cannabis pharmaceutical
Tribal meeting Lesotho

Heath & Wellness Medicine

Cannsun seeks to enhance the lives people around the world by producing the highest quality, natural, pure African and Greek cannabinoids and botanicals, providing state of the art medical solutions. Our projected growth indicates that we will be the largest cultivator of medical grade cannabis plants in Africa and Southern Europe, positioning us uniquely to provide cutting edge bio-cannabinoid medical solutions. Cannsun has extensive expertise and proven a track record in bringing a product in healthcare market.

Cannsun continues to grow and develop pharmaceutical model while merging traditional medicines to include cannabinoid alternatives for treatments of: 

Management & Directors

David Parry

Chief Executive Officer

Co-Founder of Cannsun South Africa and Chief Executive Officer of the Cannsun Medhel Group. David is also a Director of Propagation Services Canada one of the largest Cannabis facilities under glass in Canada, and Former Managing Director of Natures Hemp Ltd in Canada, a company developing food-based hemp products with the University of Manitoba and the Ontario Government. David has over 20 years working with public and private companies in the agriculture, resource and technology sectors. He has an extensive network of contacts and relationships throughout MENA, Europe, the Former Soviet Union (FSU), Asia and Africa with significant experience in mergers and acquisitions.

Aaron Katerenchuk

Chief Operating Officer

Aaron is a professional engineer holding a BSc Engineering from the University of Alberta, Canada. Aaron has 11 years experience in oil & gas specializing in project management with recent focus in acquisitions and dispositions (closing and integrating $100+ million-dollars in transactions). More recently Aaron held a position with Vibe Bioscience as Vice President of Business Development, facilitated in the process of taking Vibe public in Spring 2019 listing on the Canadian Securities Exchange. Aaron’s core focus at Vibe was product development (THC and CBD concentrates), retail, cultivation and evaluating acquisition opportunities. He has spent four years directly involved in the cannabis space with investment in cultivation, US retail and e-commerce companies both private and public.

Donaghue Woodman

Head of Women’s Health & Chief Science Officer
Donaghue’s role relates to regulatory aspects of the business, as well as new product and portfolio development and new business and strategic research development. Donaghue holds an MBA with a background in biochemistry and pharmacology (focusing on active molecules in natural medicines) with the South African Herbal Medicine and Science Institute. Donaghue has 9 years of sales and marketing experience within the pharmaceutical industry, in both the public and private sector, across a broad range of therapeutic areas including Woman’s health, CNS, Respiratory, Gastroenterology, Anaesthesiology, dermatology, Cystic Fibrosis, Pancreatic Cancer and Pain. Her passion is philanthropy, people and business, and she is a keynote motivational speaker for the Global Business Roundtable.

Pholoso Malatji

Co-Founder and Head of Africa
Pholoso is currently responsible for the South African business operations for Cannsun Medhel Africa and Co-Founder of Cannsun SA. He has over 12 years experience in property valuation, agricultural market development for emerging farmers, consulting for government Agro-projects & land reform, bio energy and research. Pholoso has extensive experience as an Agricultural Economist (MSc. Agric), Property Valuer (BSc. Property Studies), Enterprise Development (Syracuse University) and accredited with the SA Council of Scientific Professions. Pholoso worked as a consultant to the FAO, Sub-Saharan Africa in Agricultural Development and Feasibility program for four years.

Stephen Polakoff

Director & General Counsel
Stephen has over 20 years of experience as general counsel, legal advisor, director and project manager at corporations, funds, law firms including Deutsche Bank (UFG), Integra Group, Clifford Chance, Damac Properties and several funds. He has gathered international experience having worked in New York, Moscow, Dubai and Geneva. His experience has been very diverse across sectors and territories including joint ventures and M&A, capital markets, debt and equity financing, infrastructure and funds. He has served on the boards of AIM, TSX and AIM-listed entities as well as several funds. Stephen graduated from Georgetown University Law School and is a member of the New York Bar. He speaks English and Russian and currently resides in Barcelona.

Rorisang Ntai

Director
Rorisang has business interests in the petroleum and property development industries. He started his career at FNB Asset Management & Trust Services, after which he worked for Citadel, eventually as an investment analyst. He has an extensive network from which he can work with relevant specialists and experts to support current business interests or new project developments. He holds a BComm from (UNISA) University of South Africa and JSE RPE Exams from (SAIFM) South African Institute of Financial Markets.

Dr. Michel Georges Magouritsas

Dr. Magouritsas obtained his PhD from the University of Ferrara in Italy. He has over 35 years of pharmaceutical experience with dietary supplements and botanical medicinal products. He has also collaborated on a scientific level, both with academics and with government research organizations in Greece and abroad. Dr. Magouritsas has participated in several international scientific forums regarding the evaluation, identification, and monograph development of medicinal plants. He has done extensive research and development work on anti-aging formulations and has published his in-vitro pilot study in the official journal of the European Federation of Biotechnology.

Dr. Lola Ohonba

Director

Dr. Ohonba is a clinical pharmacist registered in Florida and Texas. She graduated with honors from Texas Southern University with a major in biology and a minor in chemistry. Popularly known as Dr. O, she later attended Union University in Jackson, Tennessee, where she obtained her Doctor of Pharmacy degree. She worked for several years as a staff pharmacist for a major retail pharmacy chain. After many years of direct patient care, Dr. O transitioned to one of the top Fortune 500 companies where she served as a clinical pharmacist in charge of prior authorization, appeals, and grievances for Medicare, Medicaid, and commercial clients. She is a certified medical marijuana professional who is committed to educating people about the usefulness of hemp-derived CBD and medical cannabis. Dr. O is a mother of 3 teenage boys. She loves to volunteer, travel, and listen to current affairs in her spare time.

Theodoros Makrygiannis

Quality Assurance Director

Theodoros is a graduate from the University of Patras specializing in Biochemistry & Biotechnology. Theodoros was born in Vonitsa, Greece and currently holds position as Quality Assurance Director. He has over 15 years experience in management positions in the pharmaceutical sector. Theodoros has held positions in Quality Assurance and as a Qualified person for companies such as Uni Pharma S.A. and Layipharm S.A.

Bhunyanee Dethamart

Head of Operations Thailand

Bhunyanee is a Thailand-based Chemist who has built a career working for Thailand and Italian based companies. The previous 17 years she has been with Eagle Chemical IND. of Thailand and Alpa SPA of Italy in roles from Research and Development Officer, Sales and Chief Operating Officer. In her role at Cannsun Medhel Group, Bhunyanee will directly support both the CEO and COO. She is a graduate of Sukhothai Thamathirat (Technology) University in 2002. Over the past several years, Bhunyanee has been in the Cannabis space making Bespoke cosmetics and natural medicine. She has been key figure in the project development in Asia.

Greg Bealer

Director of Finance
Greg obtained his Bachelor of Commerce degree majoring in Business Law and Economics from the University of Alberta, Canada. Greg recently retired after 11 years as an Investment Advisor and Portfolio Manager. He turned his core focus on the pharmaceutical and cannabis industry in 2013. Greg has been actively involved in financing of Canadian and international cannabis startups and brings both experience and knowledge of the capital markets.

Nickolas Korbis

General Manager Commercial Greece

Nickolas has a Chemistry degree from the University of Athens and a PhD in Chemical Engineering from Imperial College in London. He has received several special training courses including Commodity Trading from Wharton School (Univ. Of Pennsylvania), GMP guidelines for the Pharmaceutical Industry from Leiden University and Design for Masking Flavors for the Pharmaceutical and Food industry from Hercules R&D center, amongst others. He is a certified GMP by EMA auditor and has done numerous valuations and appraisals for the industry. Nikos has been working in Greece and abroad in both technical and managerial positions. He has been R&D manager in National Starch and Chemicals, Commercial Director in Biotrek, Vice President and Commercial Director in the Hellenic Register of Shipping, COO and IR Director in Alapis (the biggest Greek Pharma Co. at that time, raising more than €1.2B. President and CEO for Provet (biggest animal healthcare company in the Balkans) among others. He has participated in more than 40 M&A’s and has set up pharmaceutical and other companies in more than 18 countries. He has also conducted several restructuring and financing projects creating a proven track record in these fields.

Scroll to Top